MiR-184 ASO lowered caspase 3 levels and increased ZNF865 levels in MPP + treated cells, suggesting that ZNF865 protein can alleviate the damage caused by PD and therefore have nerve-protective effects. The gene discussed is CASP3; the disease is Parkinson disease.